Antitumor and antimetastasis effects of macerating solutions from an injectable chitosan‐based hydrogel on hepatocarcinoma
Source abstract
Abstract
Abstract In our previous studies, injectable chitosan‐based hydrogel (CH) was prepared and its application in surgery removal of tumor was studied. In this study, the antitumor and antimetastasis effects of the macerating solutions from CH were investigated. Our in vitro results showed that macerating solutions from CH significantly increased the proliferation of human normal liver L02 cells. In contrast, macerating solutions from CH showed significant inhibitory effects on the growth of human hepatoma Bel‐7402 cells. In a mouse H22 tumor model, intraperitoneal injection of macerating solutions from CH decreased tumor growth and prevented tumor diffusion. Tumor weight was decreased dramatically in mice treated with macerating solutions from CH. The thymus index and spleen index were significantly increased by treatment with macerating solutions from CH. Administration of macerating solutions from CH also remarkably increased serum levels of TNF‐α, IL‐2, IFN‐γ, and decreased serum VEGF content as compared with the control group treated with saline. The antimetastasis studies showed that the number of pulmonary nodules, pulmonary metastases index, and lymph nodes index were significantly decreased in experimental groups treated with macerating solutions from CH. This study provided more supporting data for the potential clinical application of CH after surgical removal of tumor. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3879–3885, 2015.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Proteoglycans and glycosaminoglycans research · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Marine Life Sciences Ocean University of China Yushan Road 5 Qingdao 266003 People's Republic of China
Funding
National “12th Five-year” High technology Research and Development Program of China
References (23)
Show source-provided references
1. 10.1016/j.ceb.2005.08.00210.1016/j.ceb.2005.08.002 ↗
2. 10.2174/138920103348974810.2174/1389201033489748 ↗
3. The safety of chitosan as a pharmaceutical excipient10.1016/j.yrtph.2009.09.015 ↗
4. 10.1080/07315724.2008.1071967110.1080/07315724.2008.10719671 ↗
5. Chitosan‐based drug nanocarriers: where do we stand?10.1016/j.jconrel.2012.03.017 ↗
6. 10.1007/s10047-005-0313-010.1007/s10047-005-0313-0 ↗
7. 10.1016/j.bbagen.2004.11.00910.1016/j.bbagen.2004.11.009 ↗
8. 10.1093/jn/134.4.94510.1093/jn/134.4.945 ↗
9. 10.1016/S0141-8130(02)00064-810.1016/S0141-8130(02)00064-8 ↗
10. 10.1016/j.carres.2005.02.02810.1016/j.carres.2005.02.028 ↗
11. SongFL ShaoK LiuWS HanBQ MaHN.valuation of a chitosan‐based in situ forming hydrogel.J Funct Mat2014(E):09065–09069
12. An in situ formed biodegradable hydrogel for reconstruction of the corneal endothelium10.1016/j.colsurfb.2010.07.043 ↗
13. Sensitivity of K562 and HL‐60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species
14. 10.1097/MAJ.0b013e31822b02f410.1097/MAJ.0b013e31822b02f4 ↗
15. 10.1016/j.intimp.2006.06.00310.1016/j.intimp.2006.06.003 ↗
16. 10.1016/S0939-6411(03)00095-X10.1016/S0939-6411(03)00095-X ↗
17. Anti‐tumor effects of Astragalus on hepatocellular carcinoma in vivo
18. 10.1016/S0142-9612(02)00465-910.1016/S0142-9612(02)00465-9 ↗
19. 10.1016/j.biomaterials.2009.01.02010.1016/j.biomaterials.2009.01.020 ↗
20. 10.1016/j.biomaterials.2009.05.03110.1016/j.biomaterials.2009.05.031 ↗
21. 10.1111/j.1349-7006.1994.tb02904.x10.1111/j.1349-7006.1994.tb02904.x ↗
22. 10.1016/j.jconrel.2007.11.01810.1016/j.jconrel.2007.11.018 ↗
23. 10.1016/j.biomaterials.2009.03.02210.1016/j.biomaterials.2009.03.022 ↗